6 results
8-K
EX-99.1
XLO
Xilio Therapeutics Inc
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
officer are part of a thoughtful succession planning process jointly undertaken with the board and highlight the depth of Xilio’s internal talent,” said … and the board of directors, I want to thank Marty for his partnership in helping to develop our internal talent and rapidly translating our novel, tumor
424B4
XLO
Xilio Therapeutics Inc
22 Oct 21
Prospectus supplement with pricing info
4:02pm
with which we compete for executive talent and is appropriate for a public company. This discussion may contain forward-looking statements that are based
S-1/A
XLO
Xilio Therapeutics Inc
18 Oct 21
IPO registration (amended)
6:04am
we compete for executive talent and is appropriate for a public company. This discussion may contain forward-looking statements that are based on our
S-1
XLO
Xilio Therapeutics Inc
1 Oct 21
IPO registration
4:49pm
program is competitive with the companies with which we compete for executive talent and is appropriate for a public company. This discussion may contain
DRS/A
XLO
Xilio Therapeutics Inc
14 Sep 21
Draft registration statement (amended)
12:00am
we compete for executive talent and is appropriate for a public company. This discussion may contain forward-looking statements that are based on our
DRS
qh8zld
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next